Discovery Life Sciences, LLC

11 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Sep 2033

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

3 fees due Jan 2 to 14, 2027 · next Jan 2
2 fees due Oct 21, 2027

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 9,771,409	Consumable Cryopreserved Cells Transiently Overexpressing Gene(s) Encoding Drug Transporter Protein(s) and/or Drug Metabolizing Enzyme(s) In force Ends no later than Sep 11, 2033 · Medium confidence	In force	Ends no later than Sep 11, 2033	Medium confidence
US 9,822,160	Consumable Cryopreserved Cells Transiently Overexpressing Gene(s) Encoding Drug Transporter Protein(s) and/or Drug Metabolizing Enzyme(s) In force Ends no later than Sep 11, 2033 · Medium confidence	In force	Ends no later than Sep 11, 2033	Medium confidence
US 10,017,558	Consumable Cryopreserved Cells Transiently Overexpressing Gene(s) Encoding Drug Transporter Protein(s) In force Ends no later than Sep 11, 2033 · Medium confidence	In force	Ends no later than Sep 11, 2033	Medium confidence
US 10,047,136	Consumable Cryopreserved Cells Transiently Overexpressing Gene(s) Encoding Drug Transporter Protein(s) In force Ends no later than Sep 11, 2033 · Medium confidence	In force	Ends no later than Sep 11, 2033	Medium confidence
US 10,336,805	Consumable Cryopreserved Cells Transiently Overexpressing Gene(S) Encoding Drug Transporter Protein(S) And/Or Drug Metabolizing Enzyme(S) In force Ends no later than Sep 11, 2033 · Medium confidence	In force	Ends no later than Sep 11, 2033	Medium confidence
US 10,336,806	Consumable Cryopreserved Cells Transiently Overexpressing Gene(s) Encoding Drug Transporter Protein(s) and/or Drug Metabolizing Enzyme(s) In force Ends no later than Sep 11, 2033 · Medium confidence	In force	Ends no later than Sep 11, 2033	Medium confidence
US 10,626,158	Consumable Cryopreserved Cells Transiently Overexpressing Gene(S) Encoding Drug Transporter Protein(S) And/Or Drug Metabolizing Enzyme(S) In force Ends no later than Sep 11, 2033 · Medium confidence	In force	Ends no later than Sep 11, 2033	Medium confidence
US 10,629,064	Consumable Cryopreserved Cells Transiently Overexpressing Gene(S) Encoding Drug Transporter Protein(S) And/Or Drug Metabolizing Enzyme(S) In force Ends no later than Sep 11, 2033 · Medium confidence	In force	Ends no later than Sep 11, 2033	Medium confidence
US 9,078,430	Cell Preparation Method In force Term ends Jan 31, 2034 · High confidence	In force	Term ends Jan 31, 2034	High confidence
US 9,518,979	Novel Assay to Evaluate Drug Metabolism In force Term ends Apr 3, 2035 · High confidence	In force	Term ends Apr 3, 2035	High confidence

10 of 11 patents shown.

Pro members see all 11.

Pro members: see all 11 patents

Also on record, not counted in the 11: 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending

List them